Abstract
The responses to measles immunization administered between 6 and 12 months and after 12 months were compared in children with and without human immunodeficiency virus infection. No difference in response was found when primary measles immunization was administered between 6 and 12 months; however, children with human immunodeficiency virus infection had a significantly poorer response when immunization was given after 12 months. Early measles immunization should be considered in children with human immunodeficiency virus infection.
MeSH terms
-
Antibodies, Viral / administration & dosage
-
Antibodies, Viral / blood*
-
Case-Control Studies
-
Drug Combinations
-
Female
-
HIV Infections / immunology*
-
Humans
-
Immunity, Maternally-Acquired / immunology*
-
Immunization Schedule
-
Infant
-
Measles Vaccine / administration & dosage
-
Measles Vaccine / immunology*
-
Measles virus / immunology*
-
Measles-Mumps-Rubella Vaccine
-
Mumps Vaccine / administration & dosage
-
Mumps Vaccine / immunology
-
Rubella Vaccine / administration & dosage
-
Rubella Vaccine / immunology
Substances
-
Antibodies, Viral
-
Drug Combinations
-
Measles Vaccine
-
Measles-Mumps-Rubella Vaccine
-
Mumps Vaccine
-
Rubella Vaccine